<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"FDG-PET/CT":1,
"intravascular diffuse large B-cell lymphoma":1,
"lung biopsy":1,
"18F-FDG PET":1,
"Hürthle cell neoplasm":1,
"oncocyic adenoma":1,
"oncocytic proliferation thyroid":1,
"ultrasound":4,
"MRI":1,
"brain":1,
"prostate":1,
"Ectopic pituitary adenoma":1,
"Extracranial":1,
"Hyperthyroidism":1,
"Rathke's pouch":1,
"TSH":1,
"Anaplastic thyroid carcinoma":1,
"Goiter":2,
"Survival":2,
"PIK3R3":1,
"TGF-β":1,
"cell proliferation":1,
"lung adenocarcinoma":1,
"Germany":1,
"cancer registry":1,
"cancer survival":1,
"period analysis":1,
"CDH17":1,
"CDX2":1,
"TTF1":1,
"cadherin17":1,
"neuroendocrine tumour":1,
"Distant metastasis":1,
"Extranodal growth":1,
"Extrathyroidal extension":1,
"Lymph node metastases":2,
"Medullary thyroid carcinoma":3,
"Papillary thyroid carcinoma":12,
"Primary tumor diameter":1,
"Calcitonin":2,
"Carcinoma, medullary":1,
"Neuroendocrine tumors":1,
"OSNA":1,
"Head and neck squamous cell carcinoma":1,
"Health-related quality of life":1,
"Hypothyroidism":1,
"Intra-arterial chemotherapy":1,
"Radiation":1,
"Apoptosis":1,
"Breast cancer":4,
"Cell cycle":1,
"Koumine":1,
"Hepatocellular carcinoma":2,
"IRF1":1,
"Metastasis":2,
"Thyroid hormone":3,
"miR-130b":1,
"cancer":4,
"cancer registries":1,
"incidence":2,
"predictions":1,
"projections":1,
"surveillance":1,
"Harlequin syndrome/sign":1,
"Horner's syndrome":1,
"cervical lymphadenectomy":1,
"thyroid surgery":1,
"fibromatosis-like stroma":1,
"nodular fasciitis-like stroma":1,
"PET/CT":2,
"differentiated thyroid cancer":1,
"follow-up":1,
"Cancer incidence":1,
"Cost effectiveness":1,
"Economic burden":1,
"Thyroid cancer":12,
"Thyroidectomy":9,
"fine needle aspiration":3,
"prognosis":2,
"size":1,
"thyroid neoplasms":8,
"thyroid nodule":4,
"ultrasonography":3,
"Breast carcinoma":1,
"Cancer-associated fibroblasts (CAFs)":1,
"Progression":1,
"Tumor microenvironment":1,
"Calcium":1,
"canine":1,
"paraneoplastic":1,
"overdiagnosis":1,
"overtreatment":1,
"thyroid cancer mortality":1,
"BRAF V600":1,
"BRAF mutation":1,
"BRAF mutation survival":1,
"Graves’ disease":1,
"autoantibodies":1,
"glycoprotein-hormone receptor":1,
"small molecule ligands":1,
"thyroid-stimulating hormone receptor":1,
"IMMUNOHISTOCHEMISTRY":2,
"PAEDIATRIC PATHOLOGY":1,
"Lymph node":4,
"microwave ablation":1,
"recurrent thyroid carcinoma":1,
"CK19":1,
"Diagnosis":2,
"Well-differentiated thyroid tumors uncertain malignant potential":1,
"Cytomorphology":1,
"Hurthle cell":1,
"CT examinations":1,
"Radiation epidemiology":1,
"Reverse causation":1,
"(131)I treatment":1,
"Differentiated thyroid cancer (DTC)":1,
"Kaplan–Meier analysis method":1,
"Midkine (MK)":1,
"Receiver operating characteristic (ROC) curves":1,
"Thyroglobulin (Tg)":1,
"Papillary thyroid cancer":4,
"Pediatric":1,
"Biomarkers":1,
"Exosomes":1,
"MicroRNA":1,
"PTC":1,
"miR-146b":1,
"miR-222":1,
"carcinoma":1,
"endoscopic ultrasound (EUS)":1,
"mesenchymal chondrosarcoma":1,
"pancreaticobiliary":1,
"rapid onsite evaluation":1,
"Clear cell carcinoma":1,
"LATS1":1,
"LATS2":1,
"Ovarian mucinous tumors":1,
"Ovarian serous tumors":1,
"Chernobyl disaster":1,
"Children and adolescents":1,
"hypoparathyroidism":1,
"parathyroid":2,
"substernal":1,
"18F-fluorocholine":1,
"adenoma":1,
"incidentaloma":1,
"prostate cancer":2,
"thyroid":6,
"Bajo riesgo":1,
"Clinical guideline":1,
"Cáncer de tiroides":2,
"Guía clínica":1,
"Low risk":1,
"124I":1,
"blood dosimetry":1,
"radioiodine therapy":1,
"thyroid carcinoma":4,
"BRAF":3,
"TERT":1,
"diagnostic criteria":1,
"tall cell":1,
"Central neck dissection":1,
"Lateral neck dissection":1,
"Papillary":1,
"Predictive factor":1,
"Toxic nodular goiter":1,
"carbon nanoparticles":1,
"methylene blue":1,
"Malignant":1,
"Nodule":2,
"Surgical treatment":1,
"Thyroid isthmus":1,
"Total thyroidectomy":2,
"Surveillance, Epidemiology, and End Results (SEER)":1,
"disparities":1,
"insurance":1,
"Cancer management":1,
"Meeting report":1,
"Patient-reported outcomes":1,
"Quality of life":1,
"RAS":2,
"fine-needle aspiration (FNA)":1,
"papillary carcinoma":1,
"medullary thyroid cancer":1,
"procalcitonin":1,
"Li-Fraumeni-like syndrome":1,
"Turner syndrome":1,
"genomic alterations":1,
"mosaicism":1,
"brominated diphenyl ethers":1,
"flame retardants":1,
"thyroid cancer risk":1,
"LCN2":1,
"Met/FAK cascade":1,
"thyroid hormone receptor":1,
"AEG-1":1,
"NF-kappa B":1,
"liver":1,
"non-thyroidal illness syndrome":1,
"transcriptional coactivator":1,
"Lobectomy":1,
"Mortality":1,
"Recurrence":1,
"bone metastatic niche":1,
"bone microenvironment":1,
"macrometastasis":1,
"osteoblast":1,
"osteoclast":1,
"tumor-intrinsic factors":1,
"CREB1":1,
"Ccdc6":1,
"knock-in mice":1,
"receptor":1,
"sphingosine-1-phosphate (S1P)":1,
"transient receptor potential channels (TRP channels)":1,
"vascular endothelial growth factor (VEGF)":1,
"anaplastic thyroid cancer":2,
"carfilzomib":1,
"high-throughput screening":1,
"proteasome inhibitor":1,
"Familial medullary thyroid carcinoma":1,
"Multiple endocrine neoplasia":1,
"RET":2,
"Tyrosine kinase":1,
"CECaT":1,
"Catalonia":1,
"Cataluña":1,
"TR4":1,
"miR-373-3p":1,
"Robot-assisted surgery":1,
"Robotic":1,
"Transaxillary":1,
"Airway Obstruction":1,
"Palliative Care":1,
"Stent":1,
"Meta-Analysis":1,
"Robotics":1,
"head and neck ultrasound":1,
"sonography":1,
"thyroid gland":2,
"Mantle cell lymphoma":1,
"SEER":1,
"second primary malignancies":1,
"Renal cell carcinoma":1,
"Stomach neoplasms":1,
"Synchronous triple primary cancers":1,
"cancer biomarkers":1,
"cell-free microRNA":1,
"droplet digital PCR":1,
"Neoplasms, Multiple Primary":1,
"Papillary Thyroid Microcarcinoma":1,
"Preoperative Procedures":1,
"Cancer prevention":1,
"Comet assay":1,
"Micronucleus test":1,
"Raf-B":1,
"Angelfish":1,
"Pomacanthus maculosus":1,
"histopathology":1,
"teleost":1,
"Kikuchi disease":1,
"Kikuchi-Fujimoto disease":1,
"cervical lymphadenopathy":1,
"histiocytic necrotizing lymphadenitis":1,
"68Ga":1,
"PET/CT imaging":1,
"RGD":1,
"angiogenesis":1,
"αvβ3 integrin":1,
"Bone mass index":1,
"Bone mineral density":1,
"Thyrostimulating hormone":1,
"131I whole body scintigraphy":1,
"extensive bone metastases":1,
"microcarcinoma":1,
"Hashimoto thyroiditis":1,
"prognostic value":1,
"Energy metabolism":1,
"Mitochondria":1,
"Philippines":1,
"Poorly differentiated thyroid cancer":1,
"Thyroid cancer, anaplastic":1,
"skull base metastasis":1,
"treatment":2,
"MyD88":1,
"TLR4":1,
"ERβ2":1,
"Estrogen receptor":1,
"Intra-thyroid thyroglossal duct cyst (ITTDC)":1,
"ultrasound (US)":1,
"Adverse effects":1,
"Differentiated thyroid carcinoma":1,
"Low-risk patients":1,
"Radioiodine treatment":1,
"Thyroid hormone suppression therapy":1,
"Thyroid nodules":2,
"Parathyroid glands":1,
"carbon nanoparticle":1,
"identification":1,
"lymph node excision":1,
"preservation":1,
"metastases":1,
"number of foci":1,
"poorly differentiated thyroid carcinoma":1,
"BRAF mutations":1,
"cancer model":1,
"genetically engineered mice":1,
"papillary and anaplastic thyroid cancer":1,
"pre-clinical platform":1,
"Drainage":1,
"Hemostasis":2,
"Valsalva maneuver":1,
"Iodine-131":1,
"Thyrogen":1,
"diagnostic":1,
"salivary glands":1,
"sialadenitis":1,
"99mTc methylene diphosphonate":1,
"Bone scintigraphy":1,
"CT contrast":1,
"intestinal uptake":1,
"harmonic focus curved shears":1,
"Autophagy-related gene":1,
"Clinicopathological revalance":1,
"Gene expression":1,
"Methylation":1,
"FNA":1,
"cytological findings":1,
"calcification":1,
"clinicopathological factors":1,
"thyroglobulin":1,
"adenocarcinoma":1,
"fluorodeoxyglucose-positron emission tomography-computed tomography":1,
"magnetic resonance imaging":1,
"nasopharynx":1,
"thyroid transcription factor-1":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年6月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
